Drugs in Context (Mar 2024)

Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts

  • José Antonio Magaña Serrano,
  • José Angel Cigarroa López,
  • Adolfo Chávez Mendoza,
  • Juan Betuel Ivey-Miranda,
  • Genaro Hiram Mendoza Zavala,
  • Luis Olmos Domínguez,
  • Sergio Armando Chávez Leal,
  • José Ernesto Pombo Bartelt,
  • Eduardo Heberto Herrera-Garza,
  • Gerardo Mercado Leal,
  • Rodolfo Parra Michel,
  • Luisa Fernanda Aguilera Mora,
  • Patricia Lenny Nuriulu Escobar

DOI
https://doi.org/10.7573/dic.2024-2-5
Journal volume & issue
Vol. 13
pp. 1 – 1

Abstract

Read online

The authors wish to make the following corrections to their article: Magaña Serrano JA, Cigarroa López JA, Chávez Mendoza A, Ivey-Miranda JB, Mendoza Zavala GH, Olmos Domínguez L, Chávez Leal SA, Pombo Bartelt JE, Herrera-Garza EH, Mercado Leal G, Parra Michel R, Aguilera Mora LF, Nuriulu Escobar PL. Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts. Drugs Context. 2024;13:2023-8-1. https://doi.org/10.7573/dic.2023-8-1

Keywords